
[Federal Register: July 23, 2008 (Volume 73, Number 142)]
[Notices]               
[Page 42819]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23jy08-56]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0038]

 
Peripheral and Central Nervous System Drugs Advisory Committee; 
Notice of Postponement of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is postponing the 
meeting of the Peripheral and Central Nervous Drugs Advisory Committee 
scheduled for August 6 and 7, 2008. This meeting was announced in the 
Federal Register of July 8, 2008 (73 FR 39017). The postponement is due 
to difficulties in empanelling the necessary experts due to both 
scheduling conflicts and conflict-of-interest issues.

FOR FURTHER INFORMATION CONTACT: Diem-Kieu Ngo, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-
mail: diem.ngo@fda.hhs.gov, or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512543. Please call the Information Line for up-to-date information 
on this meeting.

    Dated: July 17, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-16814 Filed 7-22-08; 8:45 am]

BILLING CODE 4160-01-S
